We are live on ! Find out more
ITCI

Intra-Cellular Therapies Inc.
ITCI

Delisted

ITCI was delisted on the 1st of April, 2025.

Back to rankings

49 hedge funds and large institutions have $166M invested in Intra-Cellular Therapies Inc. in 2014 Q3 according to their latest regulatory filings, with 5 funds opening new positions, 21 increasing their positions, 14 reducing their positions, and 11 closing their positions.

New
Increased
Maintained
Reduced
Closed

50% more repeat investments, than reductions

Existing positions increased: 21 | Existing positions reduced: 14

11% less funds holding

Funds holding: 55 → 49 (-6)

19% less capital invested

Capital invested by funds: $204M → $166M (-$38.1M)

55% less first-time investments, than exits

New positions opened: 5 | Existing positions closed: 11

Holders
49
Holders Change
-6
Holders Change %
-10.91%
% of All Funds
1.42%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
% of All Funds
0.03%
New
5
Increased
21
Reduced
14
Closed
11
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Adage Capital Partners
Adage Capital Partners
Massachusetts
+$4.51M
2
SCM
Sarissa Capital Management
Connecticut
+$2.17M
3
Northern Trust
Northern Trust
Illinois
+$2.12M
4
RPAM
Rhenman & Partners Asset Management
Sweden
+$762K
5
Geode Capital Management
Geode Capital Management
Massachusetts
+$534K

Top Sellers

Rank Fund Capital Flow
1
Franklin Resources
Franklin Resources
California
-$4.03M
2
SFM
Sphera Funds Management
Israel
-$1.59M
3
BA
BlackRock Advisors
Delaware
-$1.37M
4
Alyeska Investment Group
Alyeska Investment Group
Illinois
-$984K
5
CS
Credit Suisse
Switzerland
-$344K
Name Holding Trade Value Shares
Change 		Change in
Stake
California State Teachers Retirement System (CalSTRS)
26
California State Teachers Retirement System (CalSTRS)
California
$433K +$5.69K +379 +1%
TA
27
Teachers Advisors
New York
$330K – – –
MLICM
28
Metropolitan Life Insurance Company (MetLife)
New York
$255K – – –
Deutsche Bank
29
Deutsche Bank
Germany
$235K -$232K -15,444 -47%
Swiss National Bank
30
Swiss National Bank
Switzerland
$233K – – –
NFA
31
Nationwide Fund Advisors
Ohio
$180K +$2.66K +177 +1%
VOYA Investment Management
32
VOYA Investment Management
Georgia
$169K – – –
ST
33
Stifel Trust
Missouri
$165K +$15K +1,000 +9%
RhumbLine Advisers
34
RhumbLine Advisers
Massachusetts
$161K – – –
AIG
35
American International Group
New York
$153K -$105 -7 -0.1%
Goldman Sachs
36
Goldman Sachs
New York
$149K -$223K -14,848 -58%
TRCT
37
Tower Research Capital (TRC)
New York
$125K +$80.3K +5,346 +140%
Legal & General Group
38
Legal & General Group
United Kingdom
$48K +$50.2K +3,343 New
SO
39
STRS Ohio
Ohio
$32K +$35.6K +2,370 New
AllianceBernstein
40
AllianceBernstein
Tennessee
$23K -$10.5K -700 -29%
BNP Paribas Financial Markets
41
BNP Paribas Financial Markets
France
$14K +$15.4K +1,023 New
Wells Fargo
42
Wells Fargo
California
$11K -$6.46K -430 -35%
Teacher Retirement System of Texas
43
Teacher Retirement System of Texas
Texas
$10K +$436 +29 +4%
Citigroup
44
Citigroup
New York
$8K +$6.76K +450 +313%
GSC
45
Ground Swell Capital
South Carolina
$8K +$9.24K +615 New
Barclays
46
Barclays
United Kingdom
$7K +$2.79K +186 +46%
Bank of America
47
Bank of America
North Carolina
$2K -$63.4K -4,219 -96%
Manulife (Manufacturers Life Insurance)
48
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$150 +$2.64K +176 +2%
SFM
49
Sphera Funds Management
Israel
– -$1.59M -94,300 Closed
CS
50
Credit Suisse
Switzerland
– -$344K -20,427 Closed
1
2
3

ITCI Hedge Fund Activity: Q3 2014 in Review

49 of the 3,446 institutional investors tracked by Wall St. Rank reported a position in Intra-Cellular Therapies Inc. (ITCI) for Q3 2014, worth a combined $166M — down 19% from $204M a quarter earlier.

Sellers outnumbered buyers: 11 funds closed out of ITCI and 5 opened new positions — a net loss of 6 holders — while 14 trimmed existing stakes and 21 added.

The largest buyer was Adage Capital Partners, adding an estimated $4.51M. The largest seller was Franklin Resources, cutting an estimated $4.03M.

  • 49 institutional investors held Intra-Cellular Therapies Inc. (ITCI) as of Q3 2014, down from 55 in Q2 2014.
  • Funds reported $166M of Intra-Cellular Therapies Inc. stock for Q3 2014, down 19% quarter-over-quarter.
  • 5 funds opened new Intra-Cellular Therapies Inc. positions in Q3 2014 and 11 closed out, a net change of -6 holders.
  • The largest Intra-Cellular Therapies Inc. buyer in Q3 2014 was Adage Capital Partners, an estimated $4.51M added.
  • The largest Intra-Cellular Therapies Inc. seller in Q3 2014 was Franklin Resources, an estimated $4.03M sold.

Based on aggregated 13F filings for Q3 2014.